City Therapeutics Upsizes IPO, Raises About $200 Million
City Therapeutics priced its upsized initial public offering at the midpoint of expectations, raising about $200 million. Shares are set to begin trading Friday.
City Therapeutics shares are expected to begin trading Friday after the clinical-stage biotechnology company priced its upsized initial public offering at the midpoint of expectations. The offering is raising about $200 million. Late Thursday, City said it is selling more than 11.1 million shares.